SHAKER HEIGHTS,
Ohio , May 30, 2023 /PRNewswire/ --
Gardiner Healthcare Acquisitions Corp. (NASDAQ: GDNR, the
"Company") announced today that it received a notice (the "Notice")
on May 23, 2023 from The Nasdaq Stock
Market LLC ("Nasdaq") stating that the Company is not in compliance
with the requirements for continued listing under Nasdaq Listing
Rule 5250(c)(1) (the "Listing Rule") because the Company has not
yet filed its Quarterly Report on Form 10-Q for the period ended
March 31, 2023 (the "Form 10-Q") with the Securities and Exchange
Commission (the "SEC").
The Notice has no immediate effect on the listing
or trading of the Company's common stock on the Nasdaq Global
Market. The Notice states that the Company has 60 calendar days
from the date of the Notice, or July 24,
2023, to submit a plan to regain compliance with the Listing
Rule. If Nasdaq accepts the Company's plan to regain compliance,
then Nasdaq may grant the Company up to 180 calendar days from the
prescribed due date of the Form 10-Q, or November 20, 2023, to file the Form 10-Q to
regain compliance. The Company continues to work diligently to
finalize its Form 10-Q and plans to file its Form 10-Q as promptly
as possible to regain compliance with the Listing Rule.
This announcement is made in compliance with Nasdaq Listing Rule
5810(b), which requires disclosure of receipt of a deficiency
notification.
The Company is a blank check company formed for
the purpose of effecting a merger, share exchange, asset
acquisition, stock purchase, reorganization, or similar business
combination with one or more businesses. While the Company may
pursue an initial business combination target in any business or
industry, it intends to focus its search on the healthcare or
healthcare related industries. The Company is sponsored by the
Gardiner Healthcare Holdings, LLC, Chardan Gardiner LLC, and CCMAUS
Pty Ltd.
This press release does not constitute an offer
to sell or the solicitation of an offer to buy any securities. Any
offers, solicitations or offers to buy, or any sales of securities
will be made in accordance with the registration requirements of
the Securities Act of 1933, as amended ("Securities Act"). This
announcement is being issued in accordance with Rule 135 under the
Securities Act.
Contact:
Marc
F. Pelletier, PhD
ir@gardinerhealthcare.com
View original
content:https://www.prnewswire.com/news-releases/gardiner-healthcare-acquisitions-corp-receives-notice-regarding-late-form-10-q-filing-from-the-nasdaq-stock-market-llc-301836819.html
SOURCE Gardiner Healthcare Acquisitions Corp.
